Strengthening the future to fight against cancer
Cancer Science is a wide field that covers almost every branch of cancer research and therapy. Cancers are a group of diseases in which abnormal cells violently develop and spread in the body. More than 100 different types of cancer affect humans. Internationally, it is the second leading cause of death, accounting for one in every seven deaths worldwide. Technologies in the field of Cancer Science are improving promptly. For example, some tumours can be treated with highly sophisticated precision external beam radiation therapy such as proton beam therapy. Some patients can be cured, but for others the emphasis is on effective palliative care and improving quality of life. Cancer Conferences expresses its effort to jettison the cancer from the world.
Organ Specific Cancers
Cancer is one among the primary causes of death all over the world. Organ Specific Cancers are cancers named based on the location of cancer in the parts of the body. There are different types of cancers, some of them are Head and Neck Cancer, Brain cancer, Lung cancer, Oral cancer, Liver cancer, Breast cancer, Prostate cancer, Gastric cancer, Pancreatic cancer, Kidney (Renal Cell) cancer, Leukemia and many more. Lung, prostate, colon, rectum, stomach and liver are the most common organs affected by cancer in men. The most common organs affected by cancer in women are breast, colon, rectum, lung, cervix and stomach. Cancer expresses the various developing therapies for varied cancers.
Cancer cells behave as self-regulating cells, growing without control to form tumors. Tumors develop in a series of steps. The first step is hyperplasia, In this step, there are too many cells resulting from uncontrolled cell division. These cells appear normal, but changes have occurred that result in some loss of control of growth. The second step is dysplasia, resulting from further growth, supplemented by abnormal changes to the cells. The third step requires additional changes, which result in cells that are even more abnormal and can now spread over a wider area of tissue. These cells initiate to lose their original function; such cells are called anaplastic. At this stage, because the tumor is still contained within its original location (called in situ) and is not invasive, it is not considered malignant — it is potentially malignant. The last step occurs when the cells in the tumor metastasize, which means that they can invade surrounding tissue, including the bloodstream, and spread to other locations. This is the most severe type of tumor, but not all tumors progress to this point. Non-invasive tumors are said to be benign.
Skin cancers are cancers that develop from the skin. They are due to the progression of abnormal cells that can invade or spread to other parts of the body. Skin cancer is the most common form of cancer, globally accounting for at least 40% of cases. The most common type is non-melanoma skin cancer, which happens in at least 2-3 million people per year. There are three main types of skin cancers: basal-cell skin cancer (BCC), squamous-cell skin cancer (SCC) and melanoma. The lymphomas that start in the skin are called skin lymphoma. surgical excision is the most common form of treatment for skin cancers. About 90 percent of non-melanoma skin cancers are assisted with exposure to ultraviolet (UV) radiation from the sun. Sunscreen is effective and thus recommended to avert melanoma and squamous-cell carcinoma.
The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.
A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded online at Editorial Tracking System (https://www.longdom.org/editorial-tracking/publisher.php) or forwarded to the Editorial Office at https://www.longdom.org/eye-diseases-and-disorders.html
The Journals includes around 150Abstracts and 100 Keynote speakers have given their valuable words. The meet has provided a great scope for interaction of professionals including in addition to clinical experts and top-level pathologists and scientists from around the globe, on a single platform.
Journal of Molecular Oncology Research